Surveillance report describes acute flaccid myelitis cases in the United States

A surveillance report describes cases of acute flaccid myelitis (AFM) in the United States. The report type, study phase, and sample size are not reported. No specific intervention, exposure, or comparator is described, and no primary or secondary clinical outcomes are provided.

No main results are reported, including outcome measures, effect sizes, absolute numbers, statistical significance, or direction of findings. The surveillance nature of this report means it is descriptive rather than analytical.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, are not reported. No specific limitations are noted, though the absence of clinical outcome data and intervention details are inherent constraints. The practice relevance of this report is not specified, and it should be interpreted as a descriptive account rather than evidence for clinical decision-making.